Sino Biopharmaceutical Stock | 1177.HK | KYG8167W1380 | A0CBDJ

Date	Sino Biopharmaceutical Price
9/25/2024	3.10 undefined
9/24/2024	3.13 undefined
9/23/2024	3.02 undefined
9/20/2024	3.04 undefined
9/19/2024	2.99 undefined
9/17/2024	2.99 undefined
9/16/2024	2.98 undefined
9/13/2024	2.93 undefined
9/12/2024	2.83 undefined
9/11/2024	2.88 undefined
9/10/2024	2.84 undefined
9/9/2024	2.86 undefined
9/5/2024	2.89 undefined
9/4/2024	2.85 undefined
9/3/2024	2.85 undefined
9/2/2024	2.86 undefined
8/30/2024	2.94 undefined
8/29/2024	2.93 undefined
8/28/2024	2.89 undefined

Date	Sino Biopharmaceutical Revenue	Sino Biopharmaceutical EBIT	Sino Biopharmaceutical Net Income
2029e	37.97 B undefined	0 undefined	6.03 B undefined
2028e	36.63 B undefined	6.84 B undefined	4.13 B undefined
2027e	35.2 B undefined	6.31 B undefined	3.19 B undefined
2026e	36.68 B undefined	7.55 B undefined	3.67 B undefined
2025e	33.08 B undefined	7.03 B undefined	3.15 B undefined
2024e	29.92 B undefined	6.43 B undefined	3.08 B undefined
2023	26.2 B undefined	5.95 B undefined	2.33 B undefined
2022	26.03 B undefined	5.69 B undefined	2.54 B undefined
2021	26.86 B undefined	4.78 B undefined	14.61 B undefined
2020	23.65 B undefined	4.37 B undefined	2.77 B undefined
2019	24.23 B undefined	5.25 B undefined	2.76 B undefined
2018	20.89 B undefined	4.4 B undefined	9.05 B undefined
2017	14.82 B undefined	3.29 B undefined	2.17 B undefined
2016	13.54 B undefined	2.79 B undefined	1.64 B undefined
2015	12.16 B undefined	2.4 B undefined	1.49 B undefined
2014	10.94 B undefined	2.04 B undefined	1.34 B undefined
2013	7.85 B undefined	1.41 B undefined	822 M undefined
2012	6.77 B undefined	1.38 B undefined	724 M undefined
2011	4.8 B undefined	797 M undefined	384 M undefined
2010	3.56 B undefined	770 M undefined	494 M undefined
2009	2.86 B undefined	687 M undefined	350 M undefined
2008	2.04 B undefined	478 M undefined	266 M undefined
2007	1.14 B undefined	257 M undefined	219 M undefined
2006	754 M undefined	212 M undefined	145 M undefined
2005	796 M undefined	191 M undefined	1.61 B undefined
2004	1.12 B undefined	283 M undefined	179 M undefined

	Revenue	EBIT	Net Income
2004	1.12 B CNY	283 M CNY	179 M CNY
2005	796 M CNY	191 M CNY	1.61 B CNY
2006	754 M CNY	212 M CNY	145 M CNY
2007	1.14 B CNY	257 M CNY	219 M CNY
2008	2.04 B CNY	478 M CNY	266 M CNY
2009	2.86 B CNY	687 M CNY	350 M CNY
2010	3.56 B CNY	770 M CNY	494 M CNY
2011	4.8 B CNY	797 M CNY	384 M CNY
2012	6.77 B CNY	1.38 B CNY	724 M CNY
2013	7.85 B CNY	1.41 B CNY	822 M CNY
2014	10.94 B CNY	2.04 B CNY	1.34 B CNY
2015	12.16 B CNY	2.4 B CNY	1.49 B CNY
2016	13.54 B CNY	2.79 B CNY	1.64 B CNY
2017	14.82 B CNY	3.29 B CNY	2.17 B CNY
2018	20.89 B CNY	4.4 B CNY	9.05 B CNY
2019	24.23 B CNY	5.25 B CNY	2.76 B CNY
2020	23.65 B CNY	4.37 B CNY	2.77 B CNY
2021	26.86 B CNY	4.78 B CNY	14.61 B CNY
2022	26.03 B CNY	5.69 B CNY	2.54 B CNY
2023	26.2 B CNY	5.95 B CNY	2.33 B CNY
2024e	29.92 B CNY	6.43 B CNY	3.08 B CNY
2025e	33.08 B CNY	7.03 B CNY	3.15 B CNY
2026e	36.68 B CNY	7.55 B CNY	3.67 B CNY
2027e	35.2 B CNY	6.31 B CNY	3.19 B CNY
2028e	36.63 B CNY	6.84 B CNY	4.13 B CNY
2029e	37.97 B CNY	0 CNY	6.03 B CNY

Sino Biopharmaceutical Gross margin	Sino Biopharmaceutical Profit margin	Sino Biopharmaceutical EBIT margin	Sino Biopharmaceutical Profit margin
2029e	80.95 %	0 %	15.89 %
2028e	80.95 %	18.68 %	11.28 %
2027e	80.95 %	17.93 %	9.08 %
2026e	80.95 %	20.59 %	10 %
2025e	80.95 %	21.25 %	9.51 %
2024e	80.95 %	21.48 %	10.31 %
2023	80.95 %	22.69 %	8.9 %
2022	82.76 %	21.87 %	9.77 %
2021	80.15 %	17.79 %	54.38 %
2020	78.08 %	18.49 %	11.72 %
2019	79.67 %	21.65 %	11.4 %
2018	79.91 %	21.05 %	43.31 %
2017	79.14 %	22.22 %	14.65 %
2016	79.2 %	20.62 %	12.09 %
2015	77.67 %	19.7 %	12.22 %
2014	76.41 %	18.66 %	12.22 %
2013	77.49 %	17.98 %	10.48 %
2012	79.33 %	20.44 %	10.69 %
2011	78.5 %	16.6 %	8 %
2010	80.79 %	21.63 %	13.88 %
2009	80.27 %	24.04 %	12.25 %
2008	79.28 %	23.47 %	13.06 %
2007	82.29 %	22.64 %	19.3 %
2006	81.03 %	28.12 %	19.23 %
2005	81.53 %	23.99 %	202.76 %
2004	82.26 %	25.36 %	16.04 %

	Gross margin	EBIT margin	Profit margin
2004	82.26 %	25.36 %	16.04 %
2005	81.53 %	23.99 %	202.76 %
2006	81.03 %	28.12 %	19.23 %
2007	82.29 %	22.64 %	19.3 %
2008	79.28 %	23.47 %	13.06 %
2009	80.27 %	24.04 %	12.25 %
2010	80.79 %	21.63 %	13.88 %
2011	78.5 %	16.6 %	8 %
2012	79.33 %	20.44 %	10.69 %
2013	77.49 %	17.98 %	10.48 %
2014	76.41 %	18.66 %	12.22 %
2015	77.67 %	19.7 %	12.22 %
2016	79.2 %	20.62 %	12.09 %
2017	79.14 %	22.22 %	14.65 %
2018	79.91 %	21.05 %	43.31 %
2019	79.67 %	21.65 %	11.4 %
2020	78.08 %	18.49 %	11.72 %
2021	80.15 %	17.79 %	54.38 %
2022	82.76 %	21.87 %	9.77 %
2023	80.95 %	22.69 %	8.9 %
2024e	80.95 %	21.48 %	10.31 %
2025e	80.95 %	21.25 %	9.51 %
2026e	80.95 %	20.59 %	10 %
2027e	80.95 %	17.93 %	9.08 %
2028e	80.95 %	18.68 %	11.28 %
2029e	80.95 %	0 %	15.89 %

Date	Sino Biopharmaceutical Sales per Share	Sino Biopharmaceutical EBIT per share	Sino Biopharmaceutical Earnings per Share
2029e	2.07 undefined	0 undefined	0.33 undefined
2028e	2 undefined	0 undefined	0.23 undefined
2027e	1.92 undefined	0 undefined	0.17 undefined
2026e	2 undefined	0 undefined	0.2 undefined
2025e	1.8 undefined	0 undefined	0.17 undefined
2024e	1.63 undefined	0 undefined	0.17 undefined
2023	1.41 undefined	0.32 undefined	0.13 undefined
2022	1.37 undefined	0.3 undefined	0.13 undefined
2021	1.39 undefined	0.25 undefined	0.76 undefined
2020	1.26 undefined	0.23 undefined	0.15 undefined
2019	1.29 undefined	0.28 undefined	0.15 undefined
2018	1.13 undefined	0.24 undefined	0.49 undefined
2017	0.89 undefined	0.2 undefined	0.13 undefined
2016	0.81 undefined	0.17 undefined	0.1 undefined
2015	1.03 undefined	0.2 undefined	0.13 undefined
2014	0.98 undefined	0.18 undefined	0.12 undefined
2013	0.71 undefined	0.13 undefined	0.07 undefined
2012	0.61 undefined	0.12 undefined	0.07 undefined
2011	0.43 undefined	0.07 undefined	0.03 undefined
2010	0.33 undefined	0.07 undefined	0.05 undefined
2009	0.28 undefined	0.07 undefined	0.03 undefined
2008	0.2 undefined	0.05 undefined	0.03 undefined
2007	0.11 undefined	0.03 undefined	0.02 undefined
2006	0.07 undefined	0.02 undefined	0.01 undefined
2005	0.08 undefined	0.02 undefined	0.16 undefined
2004	0.11 undefined	0.03 undefined	0.02 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	0.11 CNY	0.03 CNY	0.02 CNY
2005	0.08 CNY	0.02 CNY	0.16 CNY
2006	0.07 CNY	0.02 CNY	0.01 CNY
2007	0.11 CNY	0.03 CNY	0.02 CNY
2008	0.2 CNY	0.05 CNY	0.03 CNY
2009	0.28 CNY	0.07 CNY	0.03 CNY
2010	0.33 CNY	0.07 CNY	0.05 CNY
2011	0.43 CNY	0.07 CNY	0.03 CNY
2012	0.61 CNY	0.12 CNY	0.07 CNY
2013	0.71 CNY	0.13 CNY	0.07 CNY
2014	0.98 CNY	0.18 CNY	0.12 CNY
2015	1.03 CNY	0.2 CNY	0.13 CNY
2016	0.81 CNY	0.17 CNY	0.1 CNY
2017	0.89 CNY	0.2 CNY	0.13 CNY
2018	1.13 CNY	0.24 CNY	0.49 CNY
2019	1.29 CNY	0.28 CNY	0.15 CNY
2020	1.26 CNY	0.23 CNY	0.15 CNY
2021	1.39 CNY	0.25 CNY	0.76 CNY
2022	1.37 CNY	0.3 CNY	0.13 CNY
2023	1.41 CNY	0.32 CNY	0.13 CNY
2024e	1.63 CNY	0 CNY	0.17 CNY
2025e	1.8 CNY	0 CNY	0.17 CNY
2026e	2 CNY	0 CNY	0.2 CNY
2027e	1.92 CNY	0 CNY	0.17 CNY
2028e	2 CNY	0 CNY	0.23 CNY
2029e	2.07 CNY	0 CNY	0.33 CNY

	Number of stocks
2004	9.8 B Aktien
2005	9.94 B Aktien
2006	10.19 B Aktien
2007	10.19 B Aktien
2008	10.19 B Aktien
2009	10.19 B Aktien
2010	10.92 B Aktien
2011	11.14 B Aktien
2012	11.12 B Aktien
2013	11.12 B Aktien
2014	11.12 B Aktien
2015	11.79 B Aktien
2016	16.68 B Aktien
2017	16.68 B Aktien
2018	18.55 B Aktien
2019	18.81 B Aktien
2020	18.8 B Aktien
2021	19.28 B Aktien
2022	19.02 B Aktien
2023	18.53 B Aktien
2024e	18.53 B Aktien
2025e	18.53 B Aktien
2026e	18.53 B Aktien
2027e	18.53 B Aktien
2028e	18.53 B Aktien
2029e	18.53 B Aktien

Date	Sino Biopharmaceutical Dividend
2029e	0.08 undefined
2028e	0.08 undefined
2027e	0.08 undefined
2026e	0.08 undefined
2025e	0.08 undefined
2024e	0.08 undefined
2023	0.08 undefined
2022	0.1 undefined
2021	0.04 undefined
2020	0.05 undefined
2019	0.04 undefined
2018	0.04 undefined
2017	0.03 undefined
2016	0.03 undefined
2015	0.02 undefined
2014	0.02 undefined
2013	0.01 undefined
2012	0.01 undefined
2011	0.02 undefined
2010	0.02 undefined
2009	0.01 undefined
2008	0.01 undefined
2007	0.01 undefined
2006	0.01 undefined
2005	0.02 undefined
2004	0 undefined

	Dividend	Dividend (Estimate)
2004	0 CNY	0 CNY
2005	0.02 CNY	0 CNY
2006	0.01 CNY	0 CNY
2007	0.01 CNY	0 CNY
2008	0.01 CNY	0 CNY
2009	0.01 CNY	0 CNY
2010	0.02 CNY	0 CNY
2011	0.02 CNY	0 CNY
2012	0.01 CNY	0 CNY
2013	0.01 CNY	0 CNY
2014	0.02 CNY	0 CNY
2015	0.02 CNY	0 CNY
2016	0.03 CNY	0 CNY
2017	0.03 CNY	0 CNY
2018	0.04 CNY	0 CNY
2019	0.04 CNY	0 CNY
2020	0.05 CNY	0 CNY
2021	0.04 CNY	0 CNY
2022	0.1 CNY	0 CNY
2023	0.08 CNY	0 CNY
2024e	0 CNY	0.08 CNY
2025e	0 CNY	0.08 CNY
2026e	0 CNY	0.08 CNY
2027e	0 CNY	0.08 CNY
2028e	0 CNY	0.08 CNY
2029e	0 CNY	0.08 CNY

Date	Sino Biopharmaceutical Payout ratio
2029e	45.73 %
2028e	47.38 %
2027e	45.68 %
2026e	44.13 %
2025e	52.33 %
2024e	40.58 %
2023	39.48 %
2022	76.92 %
2021	5.33 %
2020	36.18 %
2019	27.25 %
2018	7.29 %
2017	23.9 %
2016	27.16 %
2015	14.09 %
2014	16.01 %
2013	21.16 %
2012	16.93 %
2011	79.01 %
2010	47.41 %
2009	37.04 %
2008	29.63 %
2007	44.44 %
2006	66.67 %
2005	11.57 %
2004	22.22 %

	Payout ratio
2004	22.22 %
2005	11.57 %
2006	66.67 %
2007	44.44 %
2008	29.63 %
2009	37.04 %
2010	47.41 %
2011	79.01 %
2012	16.93 %
2013	21.16 %
2014	16.01 %
2015	14.09 %
2016	27.16 %
2017	23.9 %
2018	7.29 %
2019	27.25 %
2020	36.18 %
2021	5.33 %
2022	76.92 %
2023	39.48 %
2024e	40.58 %
2025e	52.33 %
2026e	44.13 %
2027e	45.68 %
2028e	47.38 %
2029e	45.73 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2021	0.11	0.33 (208.12 %)	2021 Q2
3/31/2021	0.06	0.1 (85.38 %)	2021 Q1
12/31/2020	0.05	0.04 (-4.14 %)	2020 Q4
9/30/2020	0.05	0.03 (-41.18 %)	2020 Q3
6/30/2020	0.04	0.05 (22.99 %)	2020 Q2
3/31/2020	0.05	0.04 (-2.87 %)	2020 Q1
12/31/2019	0.05	0.03 (-38.38 %)	2019 Q4
9/30/2019	0.05	0.05 (7.44 %)	2019 Q3
6/30/2019	0.04	0.04 (-4.75 %)	2019 Q2
3/31/2019	0.05	0.05 (2.77 %)	2019 Q1
12/31/2018	0.04	0.03 (-21.02 %)	2018 Q4
9/30/2018	0.05	0.04 (-14.73 %)	2018 Q3
6/30/2018	0.04	0.04 (-1.95 %)	2018 Q2
3/31/2018	0.05	0.04 (-5.98 %)	2018 Q1
12/31/2017	0.03	0.02 (-22.49 %)	2017 Q4
9/30/2017	0.03	0.04 (23.81 %)	2017 Q3
6/30/2017	0.03	0.03 (17.6 %)	2017 Q2
3/31/2017	0.03	0.04 (7.22 %)	2017 Q1
12/31/2016	0.03	0.02 (-30.92 %)	2016 Q4
9/30/2016	0.03	0.03 (-5.17 %)	2016 Q3
6/30/2016	0.02	0.03 (11.88 %)	2016 Q2
3/31/2016	0.03	0.03 (-0.23 %)	2016 Q1
12/31/2015	0.02	0.02 (-5.13 %)	2015 Q4
9/30/2015	0.03	0.03 (8.88 %)	2015 Q3
6/30/2015	0.02	0.03 (39.4 %)	2015 Q2
12/31/2014	0.02	0.02 (9.1 %)	2014 Q4
9/30/2014	0.02	0.02 (20.68 %)	2014 Q3
6/30/2014	0.01	0.01 (6.64 %)	2014 Q2
12/31/2013	0.01	0.01 (-33.29 %)	2013 Q4
9/30/2013	0.01	0.02 (16.22 %)	2013 Q3
6/30/2013	0.01	0.01 (-13.11 %)	2013 Q2
12/31/2012	0.01	0.01 (30.41 %)	2012 Q4
9/30/2012	0.01	0.01 (44.06 %)	2012 Q3
6/30/2012	0.01	0.01 (-26.98 %)	2012 Q2
12/31/2011	0.01	0.01 (4.19 %)	2011 Q4
9/30/2011	0.01	0 (-55.61 %)	2011 Q3
6/30/2011	0.01	0.01 (-2.62 %)	2011 Q2

%	Name	Stocks	Change	Date
9.12196 %	Tse (Ping)	1,672,704,241	14,301,117	4/17/2024
22.08636 %	Tse (Eric S Y)	4,050,000,000	0	12/31/2022
16.18946 %	Cheng (Cheung Ling)	2,968,678,124	2,081,643,374	4/8/2024
1.94991 %	Tse (Hsin Stephen)	357,557,270	183,310,270	4/17/2024
1.73190 %	The Vanguard Group, Inc.	317,579,763	411,000	3/31/2024
1.12657 %	Hang Seng Investment Management Ltd.	206,580,208	-11,308,823	3/31/2024
1.03851 %	BlackRock Institutional Trust Company, N.A.	190,433,518	-2,707,000	3/31/2024
0.98661 %	Bosera Asset Management Co., Ltd.	180,915,000	44,090,000	12/31/2023
0.77287 %	GF Fund Management Co., Ltd.	141,722,500	84,903,000	12/31/2023
0.76404 %	First Sentier Investors (Hong Kong) Limited	140,102,500	-9,573,000	12/31/2023
0.71072 %	Norges Bank Investment Management (NBIM)	130,325,866	20,679,988	12/31/2023
0.69320 %	State Street Global Advisors Asia Ltd.	127,113,245	498,022	10/31/2023
0.51274 %	Dimensional Fund Advisors, L.P.	94,021,990	302,000	2/29/2024
0.49384 %	BlackRock Advisors (UK) Limited	90,555,979	2,921,000	3/31/2024
0.42525 %	China Asset Management Co., Ltd.	77,977,900	28,845,512	12/31/2023
0.29526 %	Schroder Investment Management (Hong Kong) Ltd.	54,143,000	0	12/31/2023
0.25725 %	Geode Capital Management, L.L.C.	47,171,499	282,000	2/29/2024
0.22792 %	Caisse de Depot et Placement du Quebec	41,793,082	-18,844,680	12/31/2022
0.19704 %	E Fund Management Co. Ltd.	36,132,000	8,124,000	12/31/2023
0.17540 %	APG Asset Management N.V.	32,163,338	-73,099,820	9/30/2023
0.15807 %	Fidelity Management & Research Company LLC	28,984,999	28,984,999	2/29/2024
0.14200 %	Fullgoal Fund Management Co., Ltd.	26,039,000	12,695,000	12/31/2023
0.13924 %	State Street Global Advisors (US)	25,533,139	-378,000	3/31/2024
0.13794 %	First Sentier Investments (U.K.) Ltd	25,294,500	-3,547,000	12/31/2023
0.13514 %	Goldman Sachs Asset Management, L.P.	24,779,942	-63,356	3/31/2024
0.13088 %	OrbiMed Advisors, LLC	24,000,000	0	12/31/2023
0.12505 %	Charles Schwab Investment Management, Inc.	22,930,351	10,740,000	3/31/2024
0.12414 %	American Century Investment Management, Inc.	22,763,500	1,404,000	3/31/2024
0.11880 %	Pictet Asset Management Ltd.	21,784,750	-1,650,000	12/31/2023
0.10622 %	Dimensional Fund Advisors, Ltd.	19,478,500	68,000	2/29/2024
0.10089 %	Parametric Portfolio Associates LLC	18,500,500	0	1/31/2024
0.10058 %	Royal London Asset Management Ltd.	18,443,000	0	12/31/2023
0.10048 %	Aviva Investors Global Services Limited	18,425,832	-497,800	2/29/2024
0.10026 %	Mercer Global Investments Management Ltd	18,385,500	0	3/31/2024
0.09689 %	Credit Suisse Funds AG	17,767,250	-413,000	3/31/2024
0.09519 %	Royal London Asset Management (CIS) Limited_NLE	17,456,000	958,000	8/31/2023
0.09035 %	Harvest Fund Management Co., Ltd.	16,567,000	4,379,000	12/31/2023
0.08774 %	State Street Global Advisors (UK) Ltd.	16,088,482	22	3/31/2024
0.08610 %	Manulife Investment Management (North America) Limited	15,788,160	0	2/29/2024
0.08300 %	Northern Trust Global Investments Limited	15,219,249	152,000	2/29/2024
0.07948 %	BlackRock (Singapore) Limited	14,574,285	3,523,732	3/31/2024
0.07459 %	Nuveen LLC	13,677,817	0	3/31/2024
0.07337 %	Goldman Sachs Asset Management International	13,453,147	-75,990	1/31/2024
0.07068 %	DWS Investment GmbH	12,960,894	334,129	3/31/2024
0.06939 %	Wellington Management Company, LLP	12,724,770	3,731,315	2/29/2024
0.06756 %	BlackRock Investment Management (UK) Ltd.	12,388,373	-322,000	2/29/2024
0.06649 %	DWS Investments UK Limited	12,191,452	98,974	3/31/2024
0.06611 %	Penghua Fund Management Co., Ltd.	12,123,000	1,888,000	12/31/2023
0.06418 %	China Asset Management (Hong Kong) Limited	11,769,494	-494,560	3/31/2024
0.06176 %	Value Partners Ltd.	11,325,500	-278,000	12/31/2023
0.05808 %	Mediolanum International Funds Limited	10,651,000	-6,831,000	12/31/2023
0.05730 %	PGGM Vermogensbeheer B.V.	10,507,934	1,037,935	7/31/2023
0.05515 %	Amundi Asset Management, SAS	10,112,500	150,000	3/31/2024
0.05494 %	Mirae Asset Global Investments Co., Ltd.	10,074,504	-1,041,064	1/31/2024
0.05219 %	Mirae Asset Global Investments (Hong Kong) Limited	9,570,020	2,082,535	3/31/2024
0.05207 %	Legal & General Investment Management Ltd.	9,548,670	-766,000	3/31/2024
0.05173 %	UBS Asset Management (UK) Ltd.	9,485,684	343,000	3/31/2024
0.05099 %	HSBC Global Asset Management (UK) Limited	9,350,919	14,279	2/29/2024
0.05085 %	BOCI-Prudential Asset Management Ltd.	9,323,750	0	2/29/2024
0.05027 %	Degroof Petercam Asset Management	9,218,521	-3,068,200	12/31/2023
0.04599 %	UBS Asset Management (Switzerland)	8,433,750	546,000	2/29/2024
0.04300 %	Mellon Investments Corporation	7,884,150	-1,192,000	3/31/2024
0.04297 %	Amundi Japan Ltd.	7,880,000	127,000	11/30/2023
0.04261 %	China Southern Asset Management Co. Ltd.	7,813,000	2,285,000	12/31/2023
0.04206 %	Fidelity International	7,711,935	23,376	2/29/2024
0.04200 %	Handelsbanken Kapitalförvaltning AB	7,701,312	0	3/31/2024
0.03884 %	CSOP Asset Management Limited	7,123,038	137,162	3/31/2024
0.03531 %	Zürcher Kantonalbank (Asset Management)	6,474,000	1,266,000	2/29/2024
0.03316 %	HuaAn Fund Management Co., Ltd.	6,081,000	5,604,000	12/31/2023
0.03059 %	Eurizon Capital S.A.	5,609,178	-403,243	2/29/2024
0.03017 %	AEGON-INDUSTRIAL Fund Management Co., Ltd.	5,532,000	5,532,000	12/31/2023
0.02777 %	Russell Investments Limited	5,092,600	0	2/29/2024
0.02690 %	Vident Investment Advisory, LLC	4,933,000	-507,000	3/31/2024
0.02688 %	Yinhua Fund Management Co., Ltd.	4,929,000	2,874,000	12/31/2023
0.02503 %	Bank Julius Baer & Co Ltd., Singapore Branch	4,590,125	0	1/31/2024
0.02408 %	Fideuram Asset Management (Ireland) dac	4,414,750	-24,000	2/29/2024
0.02334 %	Irish Life Investment Managers Ltd.	4,280,355	0	3/31/2024
0.02316 %	ACATIS Investment Kapitalverwaltungsgesellschaft GmbH	4,247,000	0	1/31/2024
0.02297 %	British Columbia Investment Management Corp.	4,211,134	-55,703	3/31/2023
0.02272 %	Fisher Investments	4,166,250	0	2/29/2024
0.02265 %	Barrow Hanley Global Investors	4,154,173	2,752,857	2/29/2024
0.02236 %	Wanjia Asset Management Co., Ltd.	4,100,000	4,100,000	12/31/2023
0.02192 %	Goldman Sachs Advisors B.V._NLE	4,020,000	224,000	11/30/2023
0.02181 %	Tse (Theresa Y Y)	4,000,000	2,500,000	4/19/2024
0.02089 %	CCB Principal Asset Management Co., Ltd.	3,830,500	3,751,000	12/31/2023
0.01929 %	Eastspring Investments (Singapore) Limited	3,537,500	0	1/31/2024
0.01909 %	Leith Wheeler Investment Counsel Ltd.	3,501,000	234,000	12/31/2023
0.01891 %	Avantis Investors	3,467,000	30,000	3/31/2024
0.01848 %	Amundi (UK)	3,389,000	0	2/29/2024
0.01785 %	KLP Fondsforvaltning AS	3,272,830	0	2/29/2024
0.01781 %	Swedbank Robur Fonder AB	3,265,000	0	2/29/2024
0.01776 %	State Street Global Advisors Ireland Limited	3,256,750	-16,000	3/31/2024
0.01746 %	Guinness Atkinson Asset Management Inc.	3,201,000	0	2/29/2024
0.01703 %	Huatai-PineBridge Fund Management Co., Ltd.	3,123,606	172,000	12/31/2023
0.01675 %	Storebrand Kapitalforvaltning AS	3,071,998	0	2/29/2024
0.01637 %	China Universal Asset Management Co., Ltd.	3,001,500	809,000	12/31/2023
0.01598 %	Oaktree Capital Management, L.P.	2,931,000	0	6/30/2023
0.01582 %	Invesco Capital Management LLC	2,901,582	2,082	3/31/2024
0.01553 %	Krane Funds Advisors, LLC	2,848,250	-13,000	3/31/2024
0.01525 %	Vanguard Investments Australia Ltd.	2,795,701	-3,562	2/29/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Akeso, Inc	SupplierCustomer	0,86	0,61	0,76	0,71	0,89	0,37
HBM Holdings	SupplierCustomer	0,81	0,22	0,31	0,73	0,87	-
Tianjin Binhai Teda H	SupplierCustomer	0,81	0,59	0,77	0,78	0,33	-0,04
Wuxi Biologics	SupplierCustomer	0,80	0,47	0,69	0,78	0,87	-0,04
Karolinska Development B	SupplierCustomer	0,62	0,11	0,57	0,79	-0,16	-0,54
Shandong Head Group A	SupplierCustomer	0,29	0,29	0,39	0,75	0,04	-0,68
Shandong Pharm -A-	SupplierCustomer	-0,17	0,01	0,80	0,88	0,52	0,78
Genetron Holdings ADR	SupplierCustomer	-0,32	-0,04	0,67	0,72	0,88	0,62
Shanghai Medicilon A	SupplierCustomer	-0,78	-0,02	0,50	0,42	0,38	-0,58

What values and corporate philosophy does Sino Biopharmaceutical represent?

Sino Biopharmaceutical Ltd represents values of innovation, integrity, and excellence in the biopharmaceutical industry. With a commitment to improving global health, the company focuses on research, development, and commercialization of high-quality, affordable medicines. Sino Biopharmaceutical Ltd's corporate philosophy revolves around patient-centric approaches, ensuring access to innovative therapies. By leveraging their robust R&D capabilities, extensive manufacturing network, and strategic partnerships, the company aims to contribute to the well-being of patients worldwide. With a strong emphasis on ethical conduct, Sino Biopharmaceutical Ltd strives to deliver sustainable growth and create value for its stakeholders.

In which countries and regions is Sino Biopharmaceutical primarily present?

Sino Biopharmaceutical Ltd is primarily present in China, Hong Kong, and Macau.

What significant milestones has the company Sino Biopharmaceutical achieved?

Sino Biopharmaceutical Ltd, a leading pharmaceutical company, has accomplished several significant milestones in its journey. With a strong focus on innovation and research, the company has made remarkable strides in the biopharmaceutical sector. Sino Biopharmaceutical Ltd achieved the successful development and commercialization of various high-quality drugs, targeting critical therapeutic areas such as oncology, cardiovascular diseases, and infectious diseases. Additionally, the company expanded its presence globally, establishing partnerships and collaborations with renowned institutions and key players in the industry. Sino Biopharmaceutical Ltd's commitment to delivering cutting-edge healthcare solutions has garnered recognition, positioning them as a trusted and reliable leader in the pharmaceutical market.

What is the history and background of the company Sino Biopharmaceutical?

Sino Biopharmaceutical Ltd, founded in 2000, is a well-established pharmaceutical company based in China. With a strong focus on research, development, and production of innovative drugs, Sino Biopharmaceutical has gained recognition in the global healthcare industry. Over the years, the company has emerged as a major player in the Chinese pharmaceutical market, with a diverse portfolio of products ranging from prescription drugs to over-the-counter medications. Sino Biopharmaceutical is dedicated to enhancing people's quality of life by providing high-quality and affordable healthcare solutions. Through continuous innovation and strategic partnerships, the company has achieved significant growth, making it a promising investment opportunity in the pharmaceutical sector.

Who are the main competitors of Sino Biopharmaceutical in the market?

The main competitors of Sino Biopharmaceutical Ltd in the market include other prominent pharmaceutical companies such as Jiangsu Hengrui Medicine Co., Ltd., CSPC Pharmaceutical Group Limited, Hutchison China MediTech Limited, and Beijing SL Pharmaceutical Co., Ltd. These companies are renowned for their significant presence in the pharmaceutical industry and pose strong competition to Sino Biopharmaceutical Ltd.

In which industries is Sino Biopharmaceutical primarily active?

Sino Biopharmaceutical Ltd is primarily active in the pharmaceutical industry.

What is the business model of Sino Biopharmaceutical?

Sino Biopharmaceutical Ltd operates in the biopharmaceutical industry, specializing in the research, development, manufacturing, and distribution of pharmaceutical products. Their business model focuses on producing high-quality generic drugs, innovative biologics, and chemical drugs. Sino Biopharmaceutical aims to provide affordable and accessible healthcare solutions to patients globally. Through strategic partnerships and acquisitions, the company continuously expands its product portfolio and customer base. Sino Biopharmaceutical's dedication to technological advancements and R&D efforts strengthens its competitive advantage in the market, positioning them as a leading player in the biopharmaceutical sector.

What is the P/E ratio of Sino Biopharmaceutical 2024?

The Sino Biopharmaceutical P/E ratio is 18.61.

What is the P/S ratio of Sino Biopharmaceutical 2024?

The Sino Biopharmaceutical P/S ratio is 1.92.

What is the AlleAktien quality score of Sino Biopharmaceutical?

The AlleAktien quality score for Sino Biopharmaceutical is 7/10.

What is the revenue of Sino Biopharmaceutical 2024?

The expected Sino Biopharmaceutical revenue is 29.92 B CNY.

How high is the profit of Sino Biopharmaceutical 2024?

The expected Sino Biopharmaceutical profit is 3.08 B CNY.

What is the business model of Sino Biopharmaceutical

Sino Biopharmaceutical Ltd. is a pharmaceutical company based in Hong Kong that focuses on the research, development, manufacturing, and sales of pharmaceutical products. The company offers a wide range of products and services for people suffering from various diseases and health conditions. The business model of Sino Biopharmaceutical Ltd. is based on various business sectors, all of which are aimed at providing high-quality and innovative pharmaceutical products. These sectors include research and development, production and distribution of medicines, marketing and sales, biotechnology, and investment activities. The research and development department of Sino Biopharmaceutical Ltd. strives to promote innovation in drug development. The company invests heavily in the exploration of new drugs to treat diseases, including cancer, diabetes, cardiovascular diseases, and gastroenterology. The company has a strong research and development pipeline with numerous clinical trials for different drugs. The production of drugs is another important business sector of Sino Biopharmaceutical Ltd. The company has a wide range of drug production facilities, including solid dosage forms, liquid forms, and semi-solid forms. These facilities operate according to the highest international standards to ensure that the products are safe, effective, and of the highest quality. The company has a strong presence in China and also operates in the international market. It has launched a wide range of products for the treatment of various diseases. Some of the company's key products include tumor therapeutics, cardiovascular drugs, anti-infectives, digestive promoters, and the bleeding drug etamsylate. The company also has a strong marketing and sales department that is able to position and promote its products in the market. It uses a variety of distribution channels, including retail pharmacies, hospitals, physician networks, and online platforms, to sell its products. The company also has a separate biotechnology department that focuses on researching new technologies to advance medical research. It also has extensive activity in biotechnology investments. The company heavily invests in new startups and companies specializing in the development of biotechnology products. Overall, Sino Biopharmaceutical Ltd. has built a successful business model focused on providing high-quality and innovative medicines. The company has a strong presence in China and the international market, and its products are used by a wide range of customers to treat various diseases and conditions.

What is the Sino Biopharmaceutical dividend?

Sino Biopharmaceutical pays a dividend of 0.1 CNY distributed over payouts per year.

How often does Sino Biopharmaceutical pay dividends?

The dividend cannot currently be calculated for Sino Biopharmaceutical or the company does not pay out a dividend.

What is the Sino Biopharmaceutical ISIN?

The ISIN of Sino Biopharmaceutical is KYG8167W1380.

What is the Sino Biopharmaceutical WKN?

The WKN of Sino Biopharmaceutical is A0CBDJ.

What is the Sino Biopharmaceutical ticker?

The ticker of Sino Biopharmaceutical is 1177.HK.

How much dividend does Sino Biopharmaceutical pay?

Over the past 12 months, Sino Biopharmaceutical paid a dividend of 0.08 CNY . This corresponds to a dividend yield of about 2.58 %. For the coming 12 months, Sino Biopharmaceutical is expected to pay a dividend of 0.08 CNY.

What is the dividend yield of Sino Biopharmaceutical?

The current dividend yield of Sino Biopharmaceutical is 2.58 %.

When does Sino Biopharmaceutical pay dividends?

Sino Biopharmaceutical pays a quarterly dividend. This is distributed in the months of November, July, October, October.

How secure is the dividend of Sino Biopharmaceutical?

Sino Biopharmaceutical paid dividends every year for the past 26 years.

What is the dividend of Sino Biopharmaceutical?

For the upcoming 12 months, dividends amounting to 0.08 CNY are expected. This corresponds to a dividend yield of 2.69 %.

In which sector is Sino Biopharmaceutical located?

Sino Biopharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sino Biopharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sino Biopharmaceutical from 10/4/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did Sino Biopharmaceutical pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Sino Biopharmaceutical in the year 2023?

In the year 2023, Sino Biopharmaceutical distributed 0.1 CNY as dividends.

In which currency does Sino Biopharmaceutical pay out the dividend?

The dividends of Sino Biopharmaceutical are distributed in CNY.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.07	0.09	0.12	0.14	0.18	0.33	0.31	0.21	0.33	0.54	0.7	0.95	0.83	1.46	1.69	2.56	2.89	3.2	4.2	11.43	5.58	5.01	18.57	5.78
0.01	0.01	0.01	0.02	0.03	0.03	0.03	0.02	0.03	0.04	0.05	0.07	0.11	0.16	0.18	0.24	0.28	0.3	0.32	1.15	1.53	1.61	0.97	1.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
6	6	6	10	4	-55	-104	-29	-34	-187	-140	-414	-181	-248	-367	-274	-865	-277	-50	-612	-1,393	-785	-1,306	-1,163
-3	-4	-11	0	-14	-71	43	-87	-81	-14	-12	-169	150	-54	-254	-419	-378	-226	-733	-6,875	-399	-512	-12,870	642
4	2	1	1	1	1	3	2	2	8	2	5	9	7	2	39	66	76	77	153	339	215	179	339
0	0.01	0.01	0.02	0.02	0.03	0.05	0.02	0.03	0.09	0.12	0.16	0.18	0.36	0.28	0.3	0.48	0.58	0.46	0.84	1.1	0.96	0.73	0.89
0.08	0.1	0.14	0.17	0.2	0.24	0.28	0.12	0.25	0.37	0.61	0.44	0.91	1.31	1.25	2.1	1.92	2.99	3.73	5.09	5.32	5.33	5.37	6.27
-19	-32	-30	-70	-45	-109	-74	-55	-71	-170	-300	-371	-237	-318	-446	-557	-631	-805	-1,409	-1,565	-1,481	-1,495	-1,741	-1,402
-0.01	-0.02	-0.02	-0.06	-0.13	-0.1	1.53	0.01	-0.14	-0.14	-0.28	-1.17	0.01	-0.49	-0.55	-2.55	-1.54	-2.23	-1.98	-0.62	-3.82	-7.85	-2.52	-4.07
0.01	0.01	0.01	0.01	-0.08	0.01	1.6	0.06	-0.07	0.03	0.02	-0.8	0.24	-0.17	-0.1	-1.99	-0.91	-1.43	-0.57	0.95	-2.34	-6.35	-0.77	-2.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	-0.03	-0.03	0.05	0.03	0	0	0	0.03	0.04	-0.09	0.12	-0.08	-0.04	0.02	1.5	0	1.6	-0.1	0.3	5.17	5.34	-1.5	0.96
0	76	0	38	9	0	14	0	0	0	0	961	-27	0	0	0	0	0	0	-604	-32	-195	-332	-867
-0.04	-0	-0.06	0.01	-0.06	-0.16	-0.39	-0.14	-0.13	-0.16	-0.36	0.56	-0.63	-0.43	-0.42	0.77	-0.74	0.57	-1.35	-2.18	2.8	2.23	-3.23	-3.19
-28.00	-39.00	-9.00	-35.00	-51.00	-94.00	-289.00	-95.00	-33.00	-76.00	-124.00	-178.00	-192.00	-232.00	-245.00	-430.00	-497.00	-658.00	-798.00	-1,167.00	-1,512.00	-1,724.00	-452.00	-2,014.00
-9	-10	-28	-47	-49	-65	-110	-46	-132	-121	-149	-339	-328	-160	-195	-293	-248	-375	-449	-710	-819	-1,187	-938	-1,267
0.02	0.08	0.05	0.12	0.01	-0.01	1.42	-0.01	-0	0.1	-0.05	-0.1	0.33	0.39	0.31	0.25	-0.53	1.38	0.19	2.54	4.4	-0.01	-1.02	-0.94
57.7	71	104.7	98.7	155.8	132.4	203.5	59.9	174.5	200.4	305.1	66.2	671.4	989.9	802.8	1,544.25	1,290.17	2,189.85	2,322.81	3,528.67	3,843.49	3,830.18	3,625.23	4,862.48
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - Direct Emissions	16,093.3
Scope 2 - Indirect emissions from purchased energy	260,991
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	277,084
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	✅
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	✅
Hazardous substances	✅
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	47
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	Sino Biopharmaceutical Ticker
DÜSSELDORF	SMZ1.DU
FRANKFURT	SMZ1.F
HKSE	1177.HK
MUNICH	SMZ1.MU
PNK	SBMFF
SIX	SMZ1.SW

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
0.32	0.41	0.56	0.74	0.87	1.12	0.8	0.75	1.14	2.04	2.86	3.56	4.8	6.77	7.85	10.94	12.16	13.54	14.82	20.89	24.23	23.65	26.86	26.03	26.2	29.92	33.08	36.68	35.2	36.63	37.97
-	29.47	36.08	30.78	18.78	27.84	-28.67	-5.28	50.53	79.47	40.30	24.56	34.86	41.05	15.87	39.42	11.19	11.34	9.42	40.95	16.02	-2.42	13.59	-3.11	0.66	14.20	10.55	10.88	-4.02	4.06	3.66
72.41	78.45	80.96	79.05	79.50	82.26	81.53	81.03	82.29	79.28	80.27	80.79	78.50	79.33	77.49	76.41	77.66	79.20	79.14	79.91	79.67	78.08	80.15	82.76	80.95	-	-	-	-	-	-
0.23	0.32	0.46	0.58	0.69	0.92	0.65	0.61	0.93	1.62	2.29	2.88	3.77	5.37	6.08	8.36	9.45	10.73	11.73	16.69	19.31	18.46	21.53	21.54	21.21	0	0	0	0	0	0
0.06	0.09	0.12	0.15	0.18	0.28	0.19	0.21	0.26	0.48	0.69	0.77	0.8	1.38	1.41	2.04	2.4	2.79	3.29	4.4	5.25	4.37	4.78	5.69	5.95	6.43	7.03	7.55	6.31	6.84	0
19.12	21.55	20.64	19.73	20.39	25.36	23.99	28.12	22.64	23.47	24.04	21.63	16.60	20.44	17.98	18.66	19.70	20.62	22.21	21.05	21.65	18.48	17.79	21.87	22.69	21.48	21.25	20.59	17.93	18.68	-
0.04	0.05	0.07	0.06	0.09	0.18	1.61	0.15	0.22	0.27	0.35	0.49	0.38	0.72	0.82	1.34	1.49	1.64	2.17	9.05	2.76	2.77	14.61	2.54	2.33	3.08	3.15	3.67	3.19	4.13	6.03
-	26.32	37.50	-7.58	42.62	105.75	801.68	-91.02	51.03	21.46	31.58	41.14	-22.27	88.54	13.54	62.65	11.22	10.09	32.56	316.87	-69.48	0.36	427.17	-82.59	-8.34	32.30	1.98	16.57	-12.88	29.40	45.97
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
6.48	6.91	8.58	9.17	9.95	9.8	9.94	10.19	10.19	10.19	10.19	10.92	11.14	11.12	11.12	11.12	11.79	16.68	16.68	18.55	18.81	18.8	19.28	19.02	18.53	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.06	0.13	0.18	0.3	0.31	0.29	1.77	1.69	1.66	1.65	1.66	2.4	1.82	2.41	2.44	4.42	4.67	8.57	9.9	13.02	19.11	16.43	15.79	16.92	14.12
0.06	0.05	0.06	0.06	0.06	0.1	0.11	0.11	0.19	0.32	0.42	0.53	0.74	1.03	1.24	1.67	1.56	2	2.05	2.92	2.71	2.91	4.22	4.64	3.78
0.02	0.03	0.01	0.01	0.01	0.03	0	0	0	0.02	0.03	0.14	0.14	0.08	0.11	0.21	1.18	1.1	0.69	0.94	0.63	1.16	1.32	1.58	2.42
0.03	0.04	0.04	0.05	0.06	0.06	0.05	0.04	0.07	0.16	0.19	0.31	0.37	0.48	0.63	0.8	0.79	0.9	0.92	1.21	1.66	1.88	1.94	2.33	1.99
0	0	0	0	0	0	0.01	0.02	0.03	0.01	0.03	0.03	0.07	0.13	0.14	0.14	0.1	0.17	0.21	0.44	0.81	0.41	0.23	0.47	1.5
0.17	0.25	0.3	0.41	0.44	0.49	1.93	1.87	1.94	2.17	2.32	3.42	3.14	4.12	4.55	7.23	8.31	12.73	13.78	18.54	24.91	22.79	23.5	25.93	23.81
0.09	0.12	0.13	0.18	0.21	0.3	0.21	0.24	0.32	0.51	0.79	1.05	1.37	1.55	1.65	2.07	2.22	2.69	3.48	5.8	7.63	8.39	8.52	9.25	9.91
0.03	0.03	0.03	0.03	0.12	0.16	0.03	0.04	0.06	0.04	0.03	0.05	0.08	0.05	0.99	1.58	2.41	1.83	2.15	1.44	2.58	11.22	25.88	25.95	26.11
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.16	1.58	0
0	0	0	0	0	0.01	0	0.02	0.03	0.04	0.05	0.06	0.06	0.07	0.07	0.14	0.17	0.18	0.22	8.35	1.32	0.92	1.06	1.25	2.23
0.01	0	0	0	0	0	0.04	0.04	0.04	0.04	0.04	0.06	0.06	0.06	0.05	0.1	0.09	0.09	0.09	13.9	0.09	0.09	0.65	0.66	0.68
0	0	0	0	0.01	0.02	0.01	0.02	0.04	0.07	0.08	0.13	0.4	0.44	0.49	1.4	0.59	0.86	1.21	1.75	0.97	3.8	0.94	1.01	0.87
0.12	0.15	0.17	0.22	0.35	0.49	0.3	0.36	0.49	0.71	0.99	1.35	1.96	2.17	3.23	5.29	5.47	5.65	7.16	31.24	12.6	24.42	38.2	39.7	39.8
0.29	0.41	0.46	0.63	0.79	0.98	2.23	2.22	2.43	2.88	3.32	4.77	5.1	6.28	7.78	12.52	13.78	18.38	20.94	49.78	37.51	47.21	61.71	65.64	63.6

26	32	32	34	35	37	59	57	53	50	100	105	100	99	96	109.19	154.92	170.03	170.03	278.85	278.45	415.9	415.44	414.9	414.62
0	0.06	0.06	0.1	0.1	0.14	0.29	0.28	0.26	0.25	0.2	1.12	1.04	1.03	1	1.14	1.02	1.13	1.13	13.02	12.94	12.67	12.56	12.46	12.42
0.09	0.12	0.17	0.18	0.22	0.3	1.56	1.55	1.53	1.58	1.78	1.69	1.67	2.21	2.77	4.19	5.18	6.61	8.13	16.46	2.44	4.09	17.93	19.07	20.06
0	1	1	0	-1	0	6	15	40	69	70	129	195	206	239	185.87	-40.08	-199.58	-466.89	-378.58	-333.1	-355.85	-450.39	-860.86	-869.29
0	3	3	3	8	9	8	11	5	15	31	49	102	135	178	225.33	171.39	199.36	251.09	287.2	37.07	400.96	533.08	93.7	216.15
0.11	0.21	0.26	0.31	0.36	0.49	1.93	1.92	1.89	1.96	2.18	3.09	3.11	3.68	4.28	5.84	6.48	7.9	9.21	29.67	15.36	17.22	30.98	31.18	32.24
0.08	0.12	0.08	0.11	0.15	0.19	0.16	0.16	0.25	0.07	0.11	0.14	0.18	0.55	0.37	0.69	0.64	0.83	0.93	1.83	1.81	1.95	1.69	1.64	1.33
0	0	0	0	0	0	0	0	0	0.16	0.23	0.33	0.45	0.78	1.09	1.47	1.72	2.27	2.56	3.08	3.43	4.19	5.15	6.3	6.72
0.01	0.01	0.01	0.02	0.03	0.03	0.01	0.01	0.02	0.2	0.27	0.45	0.44	0.17	0.49	0.87	1.07	1.19	1.46	1.85	2.19	3.22	1.78	2.35	3.21
0	0	0	0	0	0	0	0	0	0	0	0	0	0	58	0	0	0	0	0	0	0	136.13	136.13	136.13
0.06	0.03	0	0.01	0	0	0	0	0.04	0.09	0	0.02	0.04	0.02	0	0.38	1.19	1.37	0.74	2.91	0.69	1.58	6.59	9.72	11.21
0.14	0.15	0.1	0.13	0.17	0.22	0.17	0.17	0.3	0.51	0.6	0.93	1.11	1.51	2.02	3.41	4.62	5.66	5.69	9.67	8.12	10.94	15.35	20.15	22.61
0	0	0	0.05	0.08	0.05	0	0	0.02	0	0	0.11	0.03	0.02	0	1.14	0.26	1.68	2.21	0.51	7.93	13.07	5.69	4.26	1.37
0	0	0	0	0	0	0	0.01	0.01	0.03	0.04	0.06	0.04	0.03	0.05	0.07	0.06	0.17	0.18	1.52	0.42	0.17	0.88	0.83	0.78
0	0	0	0	0	0	0	8	15	7	9	22	51	72	75	105.22	118.42	201.6	241.91	532.94	480.65	608.2	902.43	880.15	673.73
0	0	0	0.05	0.08	0.05	0	0.01	0.05	0.03	0.05	0.19	0.12	0.12	0.13	1.31	0.43	2.05	2.64	2.56	8.83	13.85	7.47	5.97	2.83
0.14	0.15	0.1	0.18	0.26	0.26	0.17	0.19	0.35	0.54	0.65	1.12	1.23	1.63	2.14	4.72	5.05	7.71	8.32	12.23	16.95	24.79	22.81	26.12	25.43
0.25	0.37	0.36	0.49	0.62	0.75	2.1	2.1	2.24	2.51	2.83	4.21	4.34	5.32	6.43	10.57	11.53	15.61	17.53	41.9	32.32	42.01	53.79	57.3	57.68

Sino Biopharmaceutical Ticker	Sino Biopharmaceutical FIGI
1177:HK	BBG000C6XDL4
SMZ1:GR	BBG000CBMJX9
SMZ1:GF	BBG000CBMKG5
SMZ1:GD	BBG000CBML28
SMZ1:GS	BBG000CBMMF2
SMZ1:GM	BBG000CBMMY1
SMZ1:GB	BBG000CBMNC3
SMZ1:GI	BBG000CBMNZ8
SBMFF:US	BBG000NLPK05
SBMFF:UV	BBG000NLQVT9
1177:H1	BBG006Z3JSN4
1177:H2	BBG00F135D04
1177EUR:X2	BBG00JPCD1L4
1177EUR:XB	BBG00JPCD1M3
1177EUR:XH	BBG00JPCD1P0
1177EUR:XF	BBG00JPCD1R8
1177EUR:XE	BBG00JPCD1T6
1177EUR:XJ	BBG00JPCD1V3
1177EUR:XL	BBG00JPCD1X1
1177EUR:XG	BBG00JPCD1Y0
1177EUR:XO	BBG00JPCD1Z9
1177EUR:XS	BBG00JPCD232
1177EUR:XA	BBG00JPCD241
1177EUR:E1	BBG00JPCD250
1177EUR:XT	BBG00JPCD269
1177EUR:XW	BBG00JPCD278
1177EUR:XU	BBG00JPCD287
1177EUR:XV	BBG00JPCD296
1177EUR:XM	BBG00JPCD2B3
1177EUR:XQ	BBG00JPCD2D1
1177EUR:XX	BBG00JPCD2F9
1177EUR:XZ	BBG00JPCD2G8
1177EUR:EU	BBG00JPCD2J5
1177HKD:X2	BBG00JQDNXT2
1177HKD:XB	BBG00JQDNXV9
1177HKD:XH	BBG00JQDNXX7
1177HKD:XF	BBG00JQDNXZ5
1177HKD:XE	BBG00JQDNY38
1177HKD:XJ	BBG00JQDNY47
1177HKD:XL	BBG00JQDNY56
1177HKD:XG	BBG00JQDNY65
1177HKD:XO	BBG00JQDNY92
1177HKD:XS	BBG00JQDNYH3
1177HKD:XA	BBG00JQDNYL8
1177HKD:E1	BBG00JQDNYM7
1177HKD:XT	BBG00JQDNYN6
1177HKD:XW	BBG00JQDNYP4
1177HKD:XU	BBG00JQDNYQ3
1177HKD:XV	BBG00JQDNYS1
1177HKD:XM	BBG00JQDNYT0
1177HKD:XQ	BBG00JQDNYY4
1177HKD:XX	BBG00JQDNYZ3
1177HKD:XZ	BBG00JQDNZ08
1177HKD:EU	BBG00JQDNZ53
1177N:PO	BBG00JRFTJ02
1177N:L3	BBG00JRG0S47
1177N:B3	BBG00JRG3Q20
SMZ1:SW	BBG00LVGF6G6
SMZ1:BW	BBG00LVGF6N8
SMZ1:TH	BBG00R073XQ0
SMZ1:QT	BBG00R0BTYN4
1177EUR:EP	BBG00R0BYGP5
1177EUR:EZ	BBG00R0BYGR3
SMZ1:GZ	BBG00WFCNJ27
1177N:L1	BBG00Y7B0TW4
SMZ1:LA	BBG018H7YJ53
SMZ1:LU	BBG018J1LLR9

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker1177.HK

ISINKYG8167W1380

WKNA0CBDJ

Sino Biopharmaceutical stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Sino Biopharmaceutical Stock Price History

Sino Biopharmaceutical Revenue, EBIT, Net Income KYG8167W1380 · A0CBDJ

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Sino Biopharmaceutical Revenue, EBIT and net profit per share

Sino Biopharmaceutical Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Sino Biopharmaceutical stock margins KYG8167W1380 · A0CBDJ

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Sino Biopharmaceutical Margin History

Sino Biopharmaceutical Stock Sales Revenue, EBIT, Earnings per Share KYG8167W1380 · A0CBDJ

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Sino Biopharmaceutical Revenue, EBIT and net profit per share

Sino Biopharmaceutical business model

Sino Biopharmaceutical SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Sino Biopharmaceutical Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Sino Biopharmaceutical historical P/E ratio, EBIT, and P/S ratio.

Sino Biopharmaceutical shares outstanding KYG8167W1380 · A0CBDJ

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Sino Biopharmaceutical Stock splits

Sino Biopharmaceutical dividend history and estimates KYG8167W1380 · A0CBDJ

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Sino Biopharmaceutical Dividend History

Sino Biopharmaceutical dividend payout ratio KYG8167W1380 · A0CBDJ

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
1177.HK

ISIN
KYG8167W1380

WKN
A0CBDJ